InsidersTradesSigma
Track the 제테마 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제테마 has recorded 123 insider filings. Market capitalisation: €174.3bn. The latest transaction was reported on 3 July 2026 (Purchase). Among the most active insiders: 박종우. All data is openly available.
121
Insider Decl.
n/a
Thresholds
€277,791
27 ops.
Buy Volume
€4m
15 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,235 of 29,062 companies
25.1
score / 100
Value22
Quality28
FCF yld-2.5%
Earn yld-3.5%
EV/EBITDA26.7x
ROE-2.6%
Gross mgn48%
Net mgn-8.6%
Debt/EBITDA10.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2026
Declarations123 total
Other
Other
25 of 123 declarations
Acerca de 제테마
제테마 es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se especializa en el desarrollo y la comercialización de productos farmacéuticos.